Aptose Biosciences
APTO
#10464
Rank
HK$33.95 M
Marketcap
HK$13.30
Share price
0.00%
Change (1 day)
755.03%
Change (1 year)

Aptose Biosciences (APTO) - Cash on Hand

Cash on Hand as of March 2025 : HK$36.56 Million

According to Aptose Biosciences's latest financial reports the company has HK$36.56 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Aptose Biosciences - Cash on Hand chart (from 1997 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31HK$72.25 M-80.31%
2022-12-31HK$0.36 B-40.53%
2021-12-31HK$0.61 B-34.97%
2020-12-31HK$0.94 B24.82%
2019-12-31HK$0.76 B516.73%
2018-12-31HK$0.12 B38.03%
2017-12-31HK$89.29 M45.03%
2016-12-31HK$61.57 M-44.32%
2015-12-31HK$0.11 B
2014-05-31HK$0.21 B4314.06%
2013-05-31HK$4.91 M104.06%
2012-05-31HK$2.41 M-66.77%
2011-05-31HK$7.25 M7.48%
2010-05-31HK$6.74 M-83.82%
2009-05-31HK$41.69 M-43.7%
2008-05-31HK$74.06 M17.03%
2007-05-31HK$63.28 M7.98%
2006-05-31HK$58.61 M-55.96%
2005-05-31HK$0.13 B-12.98%
2004-05-31HK$0.15 B7.14%
2003-05-31HK$0.14 B-26.06%
2002-05-31HK$0.19 B-22.04%
2001-05-31HK$0.24 B-15.83%
2000-05-31HK$0.29 B4200.49%
1999-05-31HK$6.84 M-70.09%
1998-05-31HK$22.87 M-57.6%
1997-05-31HK$53.94 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Advaxis
ADXS
HK$37.98 M 3.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Corbus Pharmaceuticals
CRBP
HK$0.90 B 2,380.68%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
HK$4.71 B 12,783.72%๐Ÿ‡บ๐Ÿ‡ธ USA